nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP1A2—Carmustine—melanoma	0.158	0.229	CbGbCtD
Efavirenz—CYP1A2—Vemurafenib—melanoma	0.125	0.181	CbGbCtD
Efavirenz—CYP3A4—Temozolomide—melanoma	0.119	0.173	CbGbCtD
Efavirenz—CYP2D6—Vemurafenib—melanoma	0.103	0.149	CbGbCtD
Efavirenz—CYP1A2—Dacarbazine—melanoma	0.0955	0.139	CbGbCtD
Efavirenz—CYP3A4—Vemurafenib—melanoma	0.0653	0.095	CbGbCtD
Efavirenz—CYP3A4—Docetaxel—melanoma	0.0224	0.0326	CbGbCtD
Efavirenz—Hepatitis—Temozolomide—melanoma	0.000575	0.00186	CcSEcCtD
Efavirenz—Asthenia—Vemurafenib—melanoma	0.000573	0.00185	CcSEcCtD
Efavirenz—Visual impairment—Carmustine—melanoma	0.000573	0.00185	CcSEcCtD
Efavirenz—Hallucination—Temozolomide—melanoma	0.000572	0.00185	CcSEcCtD
Efavirenz—Hypoaesthesia—Temozolomide—melanoma	0.000572	0.00185	CcSEcCtD
Efavirenz—Urinary tract disorder—Temozolomide—melanoma	0.000568	0.00183	CcSEcCtD
Efavirenz—Oedema peripheral—Temozolomide—melanoma	0.000566	0.00183	CcSEcCtD
Efavirenz—Pruritus—Vemurafenib—melanoma	0.000565	0.00183	CcSEcCtD
Efavirenz—Connective tissue disorder—Temozolomide—melanoma	0.000565	0.00183	CcSEcCtD
Efavirenz—Urethral disorder—Temozolomide—melanoma	0.000563	0.00182	CcSEcCtD
Efavirenz—Alopecia—Dactinomycin—melanoma	0.000561	0.00182	CcSEcCtD
Efavirenz—Eye disorder—Carmustine—melanoma	0.000556	0.0018	CcSEcCtD
Efavirenz—Visual impairment—Temozolomide—melanoma	0.000554	0.00179	CcSEcCtD
Efavirenz—Erythema—Dactinomycin—melanoma	0.000553	0.00179	CcSEcCtD
Efavirenz—Flushing—Carmustine—melanoma	0.000552	0.00178	CcSEcCtD
Efavirenz—Ill-defined disorder—Bleomycin—melanoma	0.00055	0.00178	CcSEcCtD
Efavirenz—Anaemia—Bleomycin—melanoma	0.000548	0.00177	CcSEcCtD
Efavirenz—Diarrhoea—Vemurafenib—melanoma	0.000547	0.00177	CcSEcCtD
Efavirenz—Migraine—Docetaxel—melanoma	0.000544	0.00176	CcSEcCtD
Efavirenz—Erythema multiforme—Temozolomide—melanoma	0.000543	0.00176	CcSEcCtD
Efavirenz—Eye disorder—Temozolomide—melanoma	0.000537	0.00174	CcSEcCtD
Efavirenz—Tinnitus—Temozolomide—melanoma	0.000536	0.00173	CcSEcCtD
Efavirenz—Malaise—Bleomycin—melanoma	0.000535	0.00173	CcSEcCtD
Efavirenz—Flushing—Temozolomide—melanoma	0.000533	0.00172	CcSEcCtD
Efavirenz—Cardiac disorder—Temozolomide—melanoma	0.000533	0.00172	CcSEcCtD
Efavirenz—Arrhythmia—Carmustine—melanoma	0.000531	0.00172	CcSEcCtD
Efavirenz—Dizziness—Vemurafenib—melanoma	0.000528	0.00171	CcSEcCtD
Efavirenz—Alopecia—Carmustine—melanoma	0.000526	0.0017	CcSEcCtD
Efavirenz—Angiopathy—Temozolomide—melanoma	0.000521	0.00169	CcSEcCtD
Efavirenz—Ataxia—Docetaxel—melanoma	0.000519	0.00168	CcSEcCtD
Efavirenz—Immune system disorder—Temozolomide—melanoma	0.000519	0.00168	CcSEcCtD
Efavirenz—Mediastinal disorder—Temozolomide—melanoma	0.000518	0.00167	CcSEcCtD
Efavirenz—Erythema—Carmustine—melanoma	0.000518	0.00167	CcSEcCtD
Efavirenz—Malnutrition—Carmustine—melanoma	0.000518	0.00167	CcSEcCtD
Efavirenz—Cough—Bleomycin—melanoma	0.000518	0.00167	CcSEcCtD
Efavirenz—Ill-defined disorder—Dactinomycin—melanoma	0.000513	0.00166	CcSEcCtD
Efavirenz—Anaemia—Dactinomycin—melanoma	0.000511	0.00165	CcSEcCtD
Efavirenz—Vomiting—Vemurafenib—melanoma	0.000508	0.00164	CcSEcCtD
Efavirenz—Alopecia—Temozolomide—melanoma	0.000508	0.00164	CcSEcCtD
Efavirenz—Chest pain—Bleomycin—melanoma	0.000505	0.00163	CcSEcCtD
Efavirenz—Myalgia—Bleomycin—melanoma	0.000505	0.00163	CcSEcCtD
Efavirenz—Rash—Vemurafenib—melanoma	0.000504	0.00163	CcSEcCtD
Efavirenz—Dermatitis—Vemurafenib—melanoma	0.000503	0.00163	CcSEcCtD
Efavirenz—Back pain—Carmustine—melanoma	0.000501	0.00162	CcSEcCtD
Efavirenz—Headache—Vemurafenib—melanoma	0.0005	0.00162	CcSEcCtD
Efavirenz—Malnutrition—Temozolomide—melanoma	0.0005	0.00162	CcSEcCtD
Efavirenz—Erythema—Temozolomide—melanoma	0.0005	0.00162	CcSEcCtD
Efavirenz—Breast disorder—Docetaxel—melanoma	0.000499	0.00161	CcSEcCtD
Efavirenz—Discomfort—Bleomycin—melanoma	0.000499	0.00161	CcSEcCtD
Efavirenz—Malaise—Dactinomycin—melanoma	0.000499	0.00161	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000497	0.00161	CcSEcCtD
Efavirenz—Nasopharyngitis—Docetaxel—melanoma	0.000494	0.0016	CcSEcCtD
Efavirenz—Dysgeusia—Temozolomide—melanoma	0.00049	0.00158	CcSEcCtD
Efavirenz—Confusional state—Bleomycin—melanoma	0.000488	0.00158	CcSEcCtD
Efavirenz—Vision blurred—Carmustine—melanoma	0.000488	0.00158	CcSEcCtD
Efavirenz—Tremor—Carmustine—melanoma	0.000485	0.00157	CcSEcCtD
Efavirenz—Back pain—Temozolomide—melanoma	0.000484	0.00156	CcSEcCtD
Efavirenz—Anaemia—Carmustine—melanoma	0.000478	0.00155	CcSEcCtD
Efavirenz—Agitation—Carmustine—melanoma	0.000476	0.00154	CcSEcCtD
Efavirenz—Nausea—Vemurafenib—melanoma	0.000475	0.00153	CcSEcCtD
Efavirenz—Thrombocytopenia—Bleomycin—melanoma	0.000474	0.00153	CcSEcCtD
Efavirenz—Vision blurred—Temozolomide—melanoma	0.000471	0.00152	CcSEcCtD
Efavirenz—Myalgia—Dactinomycin—melanoma	0.000471	0.00152	CcSEcCtD
Efavirenz—Tremor—Temozolomide—melanoma	0.000469	0.00152	CcSEcCtD
Efavirenz—Discomfort—Dactinomycin—melanoma	0.000465	0.0015	CcSEcCtD
Efavirenz—Ill-defined disorder—Temozolomide—melanoma	0.000464	0.0015	CcSEcCtD
Efavirenz—Anaemia—Temozolomide—melanoma	0.000462	0.00149	CcSEcCtD
Efavirenz—Anorexia—Bleomycin—melanoma	0.000461	0.00149	CcSEcCtD
Efavirenz—Agitation—Temozolomide—melanoma	0.00046	0.00149	CcSEcCtD
Efavirenz—Angioedema—Temozolomide—melanoma	0.000457	0.00148	CcSEcCtD
Efavirenz—Pancytopenia—Docetaxel—melanoma	0.000453	0.00147	CcSEcCtD
Efavirenz—Malaise—Temozolomide—melanoma	0.000451	0.00146	CcSEcCtD
Efavirenz—Vertigo—Temozolomide—melanoma	0.000449	0.00145	CcSEcCtD
Efavirenz—Convulsion—Carmustine—melanoma	0.000449	0.00145	CcSEcCtD
Efavirenz—Hypertension—Carmustine—melanoma	0.000447	0.00144	CcSEcCtD
Efavirenz—Palpitations—Temozolomide—melanoma	0.000442	0.00143	CcSEcCtD
Efavirenz—Thrombocytopenia—Dactinomycin—melanoma	0.000442	0.00143	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Bleomycin—melanoma	0.000441	0.00143	CcSEcCtD
Efavirenz—Chest pain—Carmustine—melanoma	0.000441	0.00142	CcSEcCtD
Efavirenz—Myalgia—Carmustine—melanoma	0.000441	0.00142	CcSEcCtD
Efavirenz—Anxiety—Carmustine—melanoma	0.000439	0.00142	CcSEcCtD
Efavirenz—Cough—Temozolomide—melanoma	0.000437	0.00141	CcSEcCtD
Efavirenz—Paraesthesia—Bleomycin—melanoma	0.000435	0.0014	CcSEcCtD
Efavirenz—Convulsion—Temozolomide—melanoma	0.000433	0.0014	CcSEcCtD
Efavirenz—Hypertension—Temozolomide—melanoma	0.000432	0.0014	CcSEcCtD
Efavirenz—Dyspnoea—Bleomycin—melanoma	0.000432	0.00139	CcSEcCtD
Efavirenz—Anorexia—Dactinomycin—melanoma	0.00043	0.00139	CcSEcCtD
Efavirenz—Pneumonia—Docetaxel—melanoma	0.000428	0.00138	CcSEcCtD
Efavirenz—Confusional state—Carmustine—melanoma	0.000426	0.00138	CcSEcCtD
Efavirenz—Arthralgia—Temozolomide—melanoma	0.000426	0.00138	CcSEcCtD
Efavirenz—Myalgia—Temozolomide—melanoma	0.000426	0.00138	CcSEcCtD
Efavirenz—Infestation NOS—Docetaxel—melanoma	0.000426	0.00138	CcSEcCtD
Efavirenz—Infestation—Docetaxel—melanoma	0.000426	0.00138	CcSEcCtD
Efavirenz—Anxiety—Temozolomide—melanoma	0.000424	0.00137	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000423	0.00137	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000422	0.00136	CcSEcCtD
Efavirenz—Discomfort—Temozolomide—melanoma	0.000421	0.00136	CcSEcCtD
Efavirenz—Decreased appetite—Bleomycin—melanoma	0.000421	0.00136	CcSEcCtD
Efavirenz—Renal failure—Docetaxel—melanoma	0.000418	0.00135	CcSEcCtD
Efavirenz—Neuropathy peripheral—Docetaxel—melanoma	0.000417	0.00135	CcSEcCtD
Efavirenz—Dry mouth—Temozolomide—melanoma	0.000417	0.00135	CcSEcCtD
Efavirenz—Jaundice—Docetaxel—melanoma	0.000415	0.00134	CcSEcCtD
Efavirenz—Pain—Bleomycin—melanoma	0.000414	0.00134	CcSEcCtD
Efavirenz—Thrombocytopenia—Carmustine—melanoma	0.000414	0.00134	CcSEcCtD
Efavirenz—Tachycardia—Carmustine—melanoma	0.000412	0.00133	CcSEcCtD
Efavirenz—Confusional state—Temozolomide—melanoma	0.000412	0.00133	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000411	0.00133	CcSEcCtD
Efavirenz—Anorexia—Carmustine—melanoma	0.000403	0.0013	CcSEcCtD
Efavirenz—Hepatobiliary disease—Docetaxel—melanoma	0.000403	0.0013	CcSEcCtD
Efavirenz—Nervous system disorder—Temozolomide—melanoma	0.0004	0.00129	CcSEcCtD
Efavirenz—Thrombocytopenia—Temozolomide—melanoma	0.0004	0.00129	CcSEcCtD
Efavirenz—Feeling abnormal—Bleomycin—melanoma	0.000399	0.00129	CcSEcCtD
Efavirenz—Skin disorder—Temozolomide—melanoma	0.000397	0.00128	CcSEcCtD
Efavirenz—Hyperhidrosis—Temozolomide—melanoma	0.000395	0.00128	CcSEcCtD
Efavirenz—Decreased appetite—Dactinomycin—melanoma	0.000392	0.00127	CcSEcCtD
Efavirenz—Fatigue—Dactinomycin—melanoma	0.000389	0.00126	CcSEcCtD
Efavirenz—Anorexia—Temozolomide—melanoma	0.000389	0.00126	CcSEcCtD
Efavirenz—Pain—Dactinomycin—melanoma	0.000386	0.00125	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Carmustine—melanoma	0.000385	0.00124	CcSEcCtD
Efavirenz—Urticaria—Bleomycin—melanoma	0.000385	0.00124	CcSEcCtD
Efavirenz—Rhinitis—Docetaxel—melanoma	0.000383	0.00124	CcSEcCtD
Efavirenz—Body temperature increased—Bleomycin—melanoma	0.000383	0.00124	CcSEcCtD
Efavirenz—Hepatitis—Docetaxel—melanoma	0.000382	0.00124	CcSEcCtD
Efavirenz—Insomnia—Carmustine—melanoma	0.000382	0.00124	CcSEcCtD
Efavirenz—Hypoaesthesia—Docetaxel—melanoma	0.00038	0.00123	CcSEcCtD
Efavirenz—Paraesthesia—Carmustine—melanoma	0.000379	0.00123	CcSEcCtD
Efavirenz—Urinary tract disorder—Docetaxel—melanoma	0.000377	0.00122	CcSEcCtD
Efavirenz—Dyspnoea—Carmustine—melanoma	0.000377	0.00122	CcSEcCtD
Efavirenz—Oedema peripheral—Docetaxel—melanoma	0.000376	0.00122	CcSEcCtD
Efavirenz—Somnolence—Carmustine—melanoma	0.000376	0.00121	CcSEcCtD
Efavirenz—Connective tissue disorder—Docetaxel—melanoma	0.000376	0.00121	CcSEcCtD
Efavirenz—Urethral disorder—Docetaxel—melanoma	0.000375	0.00121	CcSEcCtD
Efavirenz—Feeling abnormal—Dactinomycin—melanoma	0.000372	0.0012	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Temozolomide—melanoma	0.000372	0.0012	CcSEcCtD
Efavirenz—Insomnia—Temozolomide—melanoma	0.000369	0.00119	CcSEcCtD
Efavirenz—Gastrointestinal pain—Dactinomycin—melanoma	0.000369	0.00119	CcSEcCtD
Efavirenz—Visual impairment—Docetaxel—melanoma	0.000368	0.00119	CcSEcCtD
Efavirenz—Decreased appetite—Carmustine—melanoma	0.000367	0.00119	CcSEcCtD
Efavirenz—Paraesthesia—Temozolomide—melanoma	0.000367	0.00119	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Carmustine—melanoma	0.000365	0.00118	CcSEcCtD
Efavirenz—Dyspnoea—Temozolomide—melanoma	0.000364	0.00118	CcSEcCtD
Efavirenz—Somnolence—Temozolomide—melanoma	0.000363	0.00117	CcSEcCtD
Efavirenz—Erythema multiforme—Docetaxel—melanoma	0.000361	0.00117	CcSEcCtD
Efavirenz—Pain—Carmustine—melanoma	0.000361	0.00117	CcSEcCtD
Efavirenz—Constipation—Carmustine—melanoma	0.000361	0.00117	CcSEcCtD
Efavirenz—Dyspepsia—Temozolomide—melanoma	0.000359	0.00116	CcSEcCtD
Efavirenz—Eye disorder—Docetaxel—melanoma	0.000357	0.00115	CcSEcCtD
Efavirenz—Body temperature increased—Dactinomycin—melanoma	0.000357	0.00115	CcSEcCtD
Efavirenz—Abdominal pain—Dactinomycin—melanoma	0.000357	0.00115	CcSEcCtD
Efavirenz—Hypersensitivity—Bleomycin—melanoma	0.000357	0.00115	CcSEcCtD
Efavirenz—Decreased appetite—Temozolomide—melanoma	0.000355	0.00115	CcSEcCtD
Efavirenz—Cardiac disorder—Docetaxel—melanoma	0.000355	0.00115	CcSEcCtD
Efavirenz—Flushing—Docetaxel—melanoma	0.000355	0.00115	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Temozolomide—melanoma	0.000352	0.00114	CcSEcCtD
Efavirenz—Fatigue—Temozolomide—melanoma	0.000352	0.00114	CcSEcCtD
Efavirenz—Pain—Temozolomide—melanoma	0.000349	0.00113	CcSEcCtD
Efavirenz—Constipation—Temozolomide—melanoma	0.000349	0.00113	CcSEcCtD
Efavirenz—Feeling abnormal—Carmustine—melanoma	0.000348	0.00113	CcSEcCtD
Efavirenz—Asthenia—Bleomycin—melanoma	0.000347	0.00112	CcSEcCtD
Efavirenz—Angiopathy—Docetaxel—melanoma	0.000347	0.00112	CcSEcCtD
Efavirenz—Gastrointestinal pain—Carmustine—melanoma	0.000345	0.00112	CcSEcCtD
Efavirenz—Immune system disorder—Docetaxel—melanoma	0.000345	0.00112	CcSEcCtD
Efavirenz—Mediastinal disorder—Docetaxel—melanoma	0.000344	0.00111	CcSEcCtD
Efavirenz—Pruritus—Bleomycin—melanoma	0.000342	0.00111	CcSEcCtD
Efavirenz—Arrhythmia—Docetaxel—melanoma	0.000341	0.0011	CcSEcCtD
Efavirenz—Alopecia—Docetaxel—melanoma	0.000338	0.00109	CcSEcCtD
Efavirenz—Feeling abnormal—Temozolomide—melanoma	0.000336	0.00109	CcSEcCtD
Efavirenz—Abdominal pain—Carmustine—melanoma	0.000334	0.00108	CcSEcCtD
Efavirenz—Body temperature increased—Carmustine—melanoma	0.000334	0.00108	CcSEcCtD
Efavirenz—Gastrointestinal pain—Temozolomide—melanoma	0.000334	0.00108	CcSEcCtD
Efavirenz—Erythema—Docetaxel—melanoma	0.000333	0.00108	CcSEcCtD
Efavirenz—Malnutrition—Docetaxel—melanoma	0.000333	0.00108	CcSEcCtD
Efavirenz—Hypersensitivity—Dactinomycin—melanoma	0.000333	0.00108	CcSEcCtD
Efavirenz—Dysgeusia—Docetaxel—melanoma	0.000326	0.00105	CcSEcCtD
Efavirenz—Urticaria—Temozolomide—melanoma	0.000324	0.00105	CcSEcCtD
Efavirenz—Asthenia—Dactinomycin—melanoma	0.000324	0.00105	CcSEcCtD
Efavirenz—Body temperature increased—Temozolomide—melanoma	0.000323	0.00104	CcSEcCtD
Efavirenz—Abdominal pain—Temozolomide—melanoma	0.000323	0.00104	CcSEcCtD
Efavirenz—Back pain—Docetaxel—melanoma	0.000322	0.00104	CcSEcCtD
Efavirenz—Hypersensitivity—Carmustine—melanoma	0.000311	0.00101	CcSEcCtD
Efavirenz—Diarrhoea—Dactinomycin—melanoma	0.000309	0.000998	CcSEcCtD
Efavirenz—Vomiting—Bleomycin—melanoma	0.000308	0.000995	CcSEcCtD
Efavirenz—Anaemia—Docetaxel—melanoma	0.000307	0.000994	CcSEcCtD
Efavirenz—Rash—Bleomycin—melanoma	0.000305	0.000987	CcSEcCtD
Efavirenz—Dermatitis—Bleomycin—melanoma	0.000305	0.000986	CcSEcCtD
Efavirenz—Asthenia—Carmustine—melanoma	0.000303	0.00098	CcSEcCtD
Efavirenz—Hypersensitivity—Temozolomide—melanoma	0.000301	0.000972	CcSEcCtD
Efavirenz—Syncope—Docetaxel—melanoma	0.000298	0.000964	CcSEcCtD
Efavirenz—Palpitations—Docetaxel—melanoma	0.000294	0.00095	CcSEcCtD
Efavirenz—Asthenia—Temozolomide—melanoma	0.000293	0.000947	CcSEcCtD
Efavirenz—Loss of consciousness—Docetaxel—melanoma	0.000292	0.000945	CcSEcCtD
Efavirenz—Cough—Docetaxel—melanoma	0.00029	0.000938	CcSEcCtD
Efavirenz—Diarrhoea—Carmustine—melanoma	0.000289	0.000934	CcSEcCtD
Efavirenz—Pruritus—Temozolomide—melanoma	0.000289	0.000934	CcSEcCtD
Efavirenz—Convulsion—Docetaxel—melanoma	0.000288	0.000932	CcSEcCtD
Efavirenz—Nausea—Bleomycin—melanoma	0.000288	0.000929	CcSEcCtD
Efavirenz—Hypertension—Docetaxel—melanoma	0.000287	0.000929	CcSEcCtD
Efavirenz—Vomiting—Dactinomycin—melanoma	0.000287	0.000928	CcSEcCtD
Efavirenz—Rash—Dactinomycin—melanoma	0.000285	0.00092	CcSEcCtD
Efavirenz—Myalgia—Docetaxel—melanoma	0.000283	0.000916	CcSEcCtD
Efavirenz—Chest pain—Docetaxel—melanoma	0.000283	0.000916	CcSEcCtD
Efavirenz—Arthralgia—Docetaxel—melanoma	0.000283	0.000916	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000281	0.000909	CcSEcCtD
Efavirenz—Dizziness—Carmustine—melanoma	0.000279	0.000903	CcSEcCtD
Efavirenz—Diarrhoea—Temozolomide—melanoma	0.000279	0.000903	CcSEcCtD
Efavirenz—Dry mouth—Docetaxel—melanoma	0.000277	0.000895	CcSEcCtD
Efavirenz—Confusional state—Docetaxel—melanoma	0.000274	0.000885	CcSEcCtD
Efavirenz—Dizziness—Temozolomide—melanoma	0.00027	0.000873	CcSEcCtD
Efavirenz—Vomiting—Carmustine—melanoma	0.000269	0.000868	CcSEcCtD
Efavirenz—Nausea—Dactinomycin—melanoma	0.000268	0.000867	CcSEcCtD
Efavirenz—Shock—Docetaxel—melanoma	0.000267	0.000864	CcSEcCtD
Efavirenz—Rash—Carmustine—melanoma	0.000266	0.000861	CcSEcCtD
Efavirenz—Nervous system disorder—Docetaxel—melanoma	0.000266	0.000861	CcSEcCtD
Efavirenz—Dermatitis—Carmustine—melanoma	0.000266	0.00086	CcSEcCtD
Efavirenz—Thrombocytopenia—Docetaxel—melanoma	0.000266	0.000859	CcSEcCtD
Efavirenz—Tachycardia—Docetaxel—melanoma	0.000265	0.000857	CcSEcCtD
Efavirenz—Headache—Carmustine—melanoma	0.000265	0.000856	CcSEcCtD
Efavirenz—Skin disorder—Docetaxel—melanoma	0.000264	0.000853	CcSEcCtD
Efavirenz—Vomiting—Temozolomide—melanoma	0.00026	0.000839	CcSEcCtD
Efavirenz—Anorexia—Docetaxel—melanoma	0.000259	0.000837	CcSEcCtD
Efavirenz—Rash—Temozolomide—melanoma	0.000257	0.000832	CcSEcCtD
Efavirenz—Dermatitis—Temozolomide—melanoma	0.000257	0.000831	CcSEcCtD
Efavirenz—Headache—Temozolomide—melanoma	0.000256	0.000827	CcSEcCtD
Efavirenz—Nausea—Carmustine—melanoma	0.000251	0.000811	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Docetaxel—melanoma	0.000247	0.0008	CcSEcCtD
Efavirenz—Insomnia—Docetaxel—melanoma	0.000246	0.000794	CcSEcCtD
Efavirenz—Paraesthesia—Docetaxel—melanoma	0.000244	0.000788	CcSEcCtD
Efavirenz—Nausea—Temozolomide—melanoma	0.000243	0.000784	CcSEcCtD
Efavirenz—Dyspnoea—Docetaxel—melanoma	0.000242	0.000783	CcSEcCtD
Efavirenz—Somnolence—Docetaxel—melanoma	0.000241	0.00078	CcSEcCtD
Efavirenz—Dyspepsia—Docetaxel—melanoma	0.000239	0.000773	CcSEcCtD
Efavirenz—Decreased appetite—Docetaxel—melanoma	0.000236	0.000763	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Docetaxel—melanoma	0.000234	0.000758	CcSEcCtD
Efavirenz—Fatigue—Docetaxel—melanoma	0.000234	0.000757	CcSEcCtD
Efavirenz—Pain—Docetaxel—melanoma	0.000232	0.000751	CcSEcCtD
Efavirenz—Constipation—Docetaxel—melanoma	0.000232	0.000751	CcSEcCtD
Efavirenz—Feeling abnormal—Docetaxel—melanoma	0.000224	0.000723	CcSEcCtD
Efavirenz—Gastrointestinal pain—Docetaxel—melanoma	0.000222	0.000718	CcSEcCtD
Efavirenz—Body temperature increased—Docetaxel—melanoma	0.000215	0.000694	CcSEcCtD
Efavirenz—Abdominal pain—Docetaxel—melanoma	0.000215	0.000694	CcSEcCtD
Efavirenz—Hypersensitivity—Docetaxel—melanoma	0.0002	0.000647	CcSEcCtD
Efavirenz—Asthenia—Docetaxel—melanoma	0.000195	0.00063	CcSEcCtD
Efavirenz—Pruritus—Docetaxel—melanoma	0.000192	0.000621	CcSEcCtD
Efavirenz—Diarrhoea—Docetaxel—melanoma	0.000186	0.000601	CcSEcCtD
Efavirenz—Dizziness—Docetaxel—melanoma	0.00018	0.00058	CcSEcCtD
Efavirenz—Vomiting—Docetaxel—melanoma	0.000173	0.000558	CcSEcCtD
Efavirenz—Rash—Docetaxel—melanoma	0.000171	0.000553	CcSEcCtD
Efavirenz—Dermatitis—Docetaxel—melanoma	0.000171	0.000553	CcSEcCtD
Efavirenz—Headache—Docetaxel—melanoma	0.00017	0.00055	CcSEcCtD
Efavirenz—Nausea—Docetaxel—melanoma	0.000161	0.000521	CcSEcCtD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	3.82e-06	0.00113	CbGpPWpGaD
Efavirenz—CYP3A4—Biological oxidations—CYP1B1—melanoma	3.81e-06	0.00112	CbGpPWpGaD
Efavirenz—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.76e-06	0.00111	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	3.74e-06	0.0011	CbGpPWpGaD
Efavirenz—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	3.64e-06	0.00107	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PLCB4—melanoma	3.61e-06	0.00106	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HS3ST5—melanoma	3.59e-06	0.00106	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—UGT2B10—melanoma	3.56e-06	0.00105	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—UGT2B10—melanoma	3.53e-06	0.00104	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	3.5e-06	0.00103	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	3.48e-06	0.00103	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SLC6A11—melanoma	3.39e-06	0.000999	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIP4K2A—melanoma	3.39e-06	0.000999	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HS3ST5—melanoma	3.31e-06	0.000975	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MTAP—melanoma	3.3e-06	0.000972	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ACER3—melanoma	3.29e-06	0.000971	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HS3ST5—melanoma	3.28e-06	0.000966	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—UGT2B10—melanoma	3.01e-06	0.000888	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	2.97e-06	0.000877	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—LUM—melanoma	2.94e-06	0.000866	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PHGDH—melanoma	2.94e-06	0.000866	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.89e-06	0.000853	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HPSE—melanoma	2.88e-06	0.00085	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CUBN—melanoma	2.83e-06	0.000834	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HS3ST5—melanoma	2.8e-06	0.000826	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SDHD—melanoma	2.73e-06	0.000806	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CSPG4—melanoma	2.73e-06	0.000806	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—BSG—melanoma	2.73e-06	0.000806	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PLCB4—melanoma	2.72e-06	0.000803	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	2.67e-06	0.000788	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GPAM—melanoma	2.65e-06	0.00078	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.64e-06	0.000778	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC6A11—melanoma	2.56e-06	0.000755	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIP4K2A—melanoma	2.56e-06	0.000755	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ACER3—melanoma	2.54e-06	0.00075	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PLCB4—melanoma	2.51e-06	0.000739	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTAP—melanoma	2.49e-06	0.000735	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PLCB4—melanoma	2.48e-06	0.000732	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	2.44e-06	0.000719	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.44e-06	0.000718	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC6A11—melanoma	2.36e-06	0.000695	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIP4K2A—melanoma	2.36e-06	0.000695	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIP4K2A—melanoma	2.34e-06	0.000689	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC6A11—melanoma	2.34e-06	0.000689	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—UGT2B10—melanoma	2.33e-06	0.000686	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTAP—melanoma	2.29e-06	0.000676	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTAP—melanoma	2.27e-06	0.00067	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.25e-06	0.000665	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PLA2G6—melanoma	2.25e-06	0.000663	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PHGDH—melanoma	2.22e-06	0.000655	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—LUM—melanoma	2.22e-06	0.000655	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.22e-06	0.000655	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HPSE—melanoma	2.18e-06	0.000642	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HS3ST5—melanoma	2.16e-06	0.000637	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CUBN—melanoma	2.14e-06	0.00063	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLCB4—melanoma	2.12e-06	0.000626	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	2.08e-06	0.000614	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SDHD—melanoma	2.06e-06	0.000609	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CSPG4—melanoma	2.06e-06	0.000609	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—BSG—melanoma	2.06e-06	0.000609	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—LUM—melanoma	2.04e-06	0.000602	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PHGDH—melanoma	2.04e-06	0.000602	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LUM—melanoma	2.03e-06	0.000597	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PHGDH—melanoma	2.03e-06	0.000597	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—VCAN—melanoma	2.02e-06	0.000596	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HPSE—melanoma	2e-06	0.000591	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GPAM—melanoma	2e-06	0.00059	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC6A11—melanoma	2e-06	0.000588	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIP4K2A—melanoma	2e-06	0.000588	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HPSE—melanoma	1.99e-06	0.000585	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CUBN—melanoma	1.97e-06	0.00058	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CUBN—melanoma	1.95e-06	0.000575	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTAP—melanoma	1.94e-06	0.000572	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CSPG4—melanoma	1.9e-06	0.00056	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—BSG—melanoma	1.9e-06	0.00056	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SDHD—melanoma	1.9e-06	0.00056	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.9e-06	0.000559	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SDHD—melanoma	1.88e-06	0.000555	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—BSG—melanoma	1.88e-06	0.000555	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CSPG4—melanoma	1.88e-06	0.000555	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GPAM—melanoma	1.84e-06	0.000542	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GPAM—melanoma	1.82e-06	0.000538	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PHGDH—melanoma	1.73e-06	0.00051	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LUM—melanoma	1.73e-06	0.00051	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP17A1—melanoma	1.71e-06	0.000503	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PLA2G6—melanoma	1.7e-06	0.000501	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HPSE—melanoma	1.7e-06	0.0005	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CUBN—melanoma	1.67e-06	0.000491	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLCB4—melanoma	1.64e-06	0.000483	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GNA11—melanoma	1.61e-06	0.000475	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SDHD—melanoma	1.61e-06	0.000474	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CSPG4—melanoma	1.61e-06	0.000474	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—BSG—melanoma	1.61e-06	0.000474	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—FASN—melanoma	1.58e-06	0.000465	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PLA2G6—melanoma	1.56e-06	0.000461	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GPAM—melanoma	1.56e-06	0.000459	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PLA2G6—melanoma	1.55e-06	0.000457	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SLC5A5—melanoma	1.55e-06	0.000457	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIP4K2A—melanoma	1.54e-06	0.000454	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC6A11—melanoma	1.54e-06	0.000454	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—VCAN—melanoma	1.53e-06	0.00045	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTAP—melanoma	1.5e-06	0.000442	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GNAQ—melanoma	1.5e-06	0.000441	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CD44—melanoma	1.5e-06	0.000441	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.45e-06	0.000426	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CYP1B1—melanoma	1.44e-06	0.000423	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—VCAN—melanoma	1.4e-06	0.000414	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.4e-06	0.000411	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—VCAN—melanoma	1.39e-06	0.000411	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PHGDH—melanoma	1.34e-06	0.000394	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LUM—melanoma	1.34e-06	0.000394	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLA2G6—melanoma	1.32e-06	0.000391	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.32e-06	0.000389	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HPSE—melanoma	1.31e-06	0.000386	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP17A1—melanoma	1.29e-06	0.00038	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CUBN—melanoma	1.29e-06	0.000379	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.27e-06	0.000375	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.27e-06	0.000375	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.25e-06	0.00037	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CSPG4—melanoma	1.24e-06	0.000366	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SDHD—melanoma	1.24e-06	0.000366	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—BSG—melanoma	1.24e-06	0.000366	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GNA11—melanoma	1.22e-06	0.000359	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPAM—melanoma	1.2e-06	0.000355	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—FASN—melanoma	1.19e-06	0.000351	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—VCAN—melanoma	1.19e-06	0.000351	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP17A1—melanoma	1.19e-06	0.000349	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ABCB1—melanoma	1.18e-06	0.000348	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP17A1—melanoma	1.17e-06	0.000346	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SLC5A5—melanoma	1.17e-06	0.000345	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.16e-06	0.000342	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.14e-06	0.000337	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CD44—melanoma	1.13e-06	0.000334	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GNAQ—melanoma	1.13e-06	0.000334	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.13e-06	0.000332	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GNA11—melanoma	1.12e-06	0.00033	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GNA11—melanoma	1.11e-06	0.000327	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.11e-06	0.000327	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.1e-06	0.000324	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—FASN—melanoma	1.1e-06	0.000323	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PRKCA—melanoma	1.09e-06	0.000321	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.09e-06	0.000321	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—FASN—melanoma	1.09e-06	0.00032	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CYP1B1—melanoma	1.08e-06	0.00032	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ERCC2—melanoma	1.08e-06	0.000318	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC5A5—melanoma	1.08e-06	0.000318	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC5A5—melanoma	1.07e-06	0.000315	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CD44—melanoma	1.04e-06	0.000307	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GNAQ—melanoma	1.04e-06	0.000307	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GNAQ—melanoma	1.03e-06	0.000304	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CD44—melanoma	1.03e-06	0.000304	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLA2G6—melanoma	1.02e-06	0.000301	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.01e-06	0.000298	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP17A1—melanoma	1e-06	0.000296	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1e-06	0.000295	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CYP1B1—melanoma	9.98e-07	0.000294	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.9e-07	0.000292	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CYP1B1—melanoma	9.89e-07	0.000292	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	9.78e-07	0.000288	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.57e-07	0.000282	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GNA11—melanoma	9.48e-07	0.00028	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—FASN—melanoma	9.28e-07	0.000274	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—VCAN—melanoma	9.18e-07	0.000271	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC5A5—melanoma	9.13e-07	0.000269	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCB1—melanoma	8.93e-07	0.000263	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GNAQ—melanoma	8.81e-07	0.00026	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CD44—melanoma	8.81e-07	0.00026	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.73e-07	0.000257	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.63e-07	0.000254	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.55e-07	0.000252	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CG—melanoma	8.52e-07	0.000251	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP1B1—melanoma	8.45e-07	0.000249	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARG—melanoma	8.22e-07	0.000242	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PRKCA—melanoma	8.22e-07	0.000242	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCB1—melanoma	8.22e-07	0.000242	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ERCC2—melanoma	8.15e-07	0.00024	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCB1—melanoma	8.14e-07	0.00024	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP17A1—melanoma	7.75e-07	0.000228	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PRKCA—melanoma	7.56e-07	0.000223	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ERCC2—melanoma	7.5e-07	0.000221	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PRKCA—melanoma	7.49e-07	0.000221	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CD—melanoma	7.49e-07	0.000221	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.46e-07	0.00022	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ERCC2—melanoma	7.43e-07	0.000219	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALB—melanoma	7.39e-07	0.000218	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GNA11—melanoma	7.32e-07	0.000216	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—FASN—melanoma	7.16e-07	0.000211	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC5A5—melanoma	7.04e-07	0.000208	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCB1—melanoma	6.96e-07	0.000205	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GNAQ—melanoma	6.8e-07	0.000201	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CD44—melanoma	6.8e-07	0.000201	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.75e-07	0.000199	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CB—melanoma	6.53e-07	0.000192	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP1B1—melanoma	6.52e-07	0.000192	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—melanoma	6.47e-07	0.000191	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CG—melanoma	6.44e-07	0.00019	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PRKCA—melanoma	6.4e-07	0.000189	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ERCC2—melanoma	6.35e-07	0.000187	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARG—melanoma	6.21e-07	0.000183	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.16e-07	0.000182	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CG—melanoma	5.92e-07	0.000175	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CG—melanoma	5.87e-07	0.000173	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARG—melanoma	5.72e-07	0.000168	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARG—melanoma	5.67e-07	0.000167	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CD—melanoma	5.66e-07	0.000167	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTEN—melanoma	5.64e-07	0.000166	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALB—melanoma	5.59e-07	0.000165	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCB1—melanoma	5.37e-07	0.000158	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.26e-07	0.000155	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CD—melanoma	5.21e-07	0.000153	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CD—melanoma	5.16e-07	0.000152	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALB—melanoma	5.14e-07	0.000152	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALB—melanoma	5.09e-07	0.00015	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CG—melanoma	5.02e-07	0.000148	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PRKCA—melanoma	4.94e-07	0.000146	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CB—melanoma	4.93e-07	0.000145	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ERCC2—melanoma	4.9e-07	0.000145	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—melanoma	4.89e-07	0.000144	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARG—melanoma	4.84e-07	0.000143	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CB—melanoma	4.54e-07	0.000134	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CB—melanoma	4.5e-07	0.000133	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—melanoma	4.5e-07	0.000133	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—melanoma	4.46e-07	0.000131	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CD—melanoma	4.41e-07	0.00013	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALB—melanoma	4.35e-07	0.000128	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTEN—melanoma	4.26e-07	0.000126	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—melanoma	3.98e-07	0.000117	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTEN—melanoma	3.92e-07	0.000116	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTEN—melanoma	3.89e-07	0.000115	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CG—melanoma	3.87e-07	0.000114	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CB—melanoma	3.84e-07	0.000113	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—melanoma	3.81e-07	0.000112	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARG—melanoma	3.74e-07	0.00011	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CD—melanoma	3.4e-07	0.0001	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALB—melanoma	3.36e-07	9.91e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTEN—melanoma	3.32e-07	9.79e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—melanoma	3.25e-07	9.58e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—melanoma	3.01e-07	8.87e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CB—melanoma	2.97e-07	8.75e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—melanoma	2.94e-07	8.67e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—melanoma	2.77e-07	8.15e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—melanoma	2.74e-07	8.08e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTEN—melanoma	2.56e-07	7.56e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—melanoma	2.46e-07	7.24e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—melanoma	2.34e-07	6.91e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—melanoma	2.26e-07	6.66e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—melanoma	2.24e-07	6.6e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—melanoma	1.91e-07	5.64e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—melanoma	1.81e-07	5.33e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—melanoma	1.48e-07	4.36e-05	CbGpPWpGaD
